Clinical Trial Update: Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma

View source ↗

Summary

This clinical trial is evaluating the diagnostic accuracy of an EBV C promoter methylation kit for nasopharyngeal carcinoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Status: RECRUITING